About Twist Bioscience
Twist Bioscience is a company based in San Francisco (United States) founded in 2013 by Emily Leproust.. Twist Bioscience has raised $245.81 million across 10 funding rounds from investors including Fidelity Investments, Illumina and SVB. The company has 923 employees as of September 30, 2024. Twist Bioscience has completed 3 acquisitions, including Abveris, Genome Compiler Corporation and iGenomX. Twist Bioscience operates in a competitive market with competitors including Amyris, Syngenta, AskBio, Ginkgo Bioworks and Antheia, among others.
- Headquarter San Francisco, United States
- Employees 923 as on 30 Sep, 2024
- Founders Emily Leproust
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Twist Bioscience Corporation
-
Annual Revenue
$312.97 M27.69as on Sep 30, 2024
-
Net Profit
$-208.73 M-2.01as on Sep 30, 2024
-
EBITDA
$-144.47 M18.65as on Sep 30, 2024
-
Total Equity Funding
$245.81 M (USD)
in 10 rounds
-
Latest Funding Round
$50 M (USD), Series F
Apr 02, 2018
-
Investors
Fidelity Investments
& 20 more
-
Employee Count
923
as on Sep 30, 2024
-
Investments & Acquisitions
Abveris
& 2 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Twist Bioscience
Twist Bioscience is a publicly listed company on the NASDAQ with ticker symbol TWST in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Unlock access to complete
Unlock access to complete
Software Development Team
76 people
Senior Team
45 people
Sales and Marketing
33 people
Product Management Team
22 people
Leadership Team
21 people
Staff Team
8 people
Research Team
7 people
Data Analysis and Operations Team
7 people
Unlock access to complete
Funding Insights of Twist Bioscience
Twist Bioscience has successfully raised a total of $245.81M across 10 strategic funding rounds. The most recent funding activity was a Series F round of $50 million completed in April 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 10
- Last Round Series F — $50.0M
-
First Round
First Round
(07 Feb 2014)
- Investors Count 21
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2018 | Amount | Series F - Twist Bioscience | Valuation |
investors |
|
| Jun, 2017 | Amount | Series E - Twist Bioscience | Valuation |
investors |
|
| Mar, 2017 | Amount | Series E - Twist Bioscience | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Twist Bioscience
Twist Bioscience has secured backing from 21 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Fidelity Investments, Illumina and SVB. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage tech and life sciences focused VC firm investing primarily in the US
|
Founded Year | Domain | Location | |
|
Private equity investments are managed across multiple sectors.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Twist Bioscience
Twist Bioscience has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Abveris, Genome Compiler Corporation and iGenomX. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Monoclonal antibodies are discovered rapidly using transgenic rodents.
|
2014 | ||||
|
NGS library construction solutions are provided to enhance DNA sequencing.
|
2012 | ||||
|
DNA design, visualization, data management, and collaboration tools are provided.
|
2011 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Twist Bioscience
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Twist Bioscience Comparisons
Competitors of Twist Bioscience
Twist Bioscience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Amyris, Syngenta, AskBio, Ginkgo Bioworks and Antheia, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of renewable products for industrial solutions
|
|
| domain | founded_year | HQ Location |
Crop protection solutions and hybrid seeds are provided for farming.
|
|
| domain | founded_year | HQ Location |
Gene and protein therapies are developed for treating various diseases.
|
|
| domain | founded_year | HQ Location |
Gene editing-based cultured ingredients are provided for agriculture.
|
|
| domain | founded_year | HQ Location |
Yeast cells are genetically engineered to produce medicinal products.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Twist Bioscience
Frequently Asked Questions about Twist Bioscience
When was Twist Bioscience founded?
Twist Bioscience was founded in 2013 and raised its 1st funding round 1 year after it was founded.
Where is Twist Bioscience located?
Twist Bioscience is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Who is the current CEO of Twist Bioscience?
Emily Leproust is the current CEO of Twist Bioscience. They have also founded this company.
Is Twist Bioscience a funded company?
Twist Bioscience is a funded company, having raised a total of $245.81M across 10 funding rounds to date. The company's 1st funding round was a Series E of $33M, raised on Feb 07, 2014.
How many employees does Twist Bioscience have?
As of Sep 30, 2024, the latest employee count at Twist Bioscience is 923.
What is the annual revenue of Twist Bioscience?
Annual revenue of Twist Bioscience is $312.97M as on Sep 30, 2024.
What does Twist Bioscience do?
Twist Bioscience was founded in 2013 in San Francisco, United States, within the biotechnology sector. A proprietary silicon-based manufacturing process is employed for producing synthetic DNA, applicable in medicine, agriculture, industrial chemicals, and data storage. Synthetic genes, oligo pools, and NGS target enrichment services are provided to facilitate research and development efforts across these fields.
Who are the top competitors of Twist Bioscience?
Twist Bioscience's top competitors include Syngenta, Synthego and Nuclera Nucleics.
Is Twist Bioscience publicly traded?
Yes, Twist Bioscience is publicly traded on NASDAQ under the ticker symbol TWST.
How many acquisitions has Twist Bioscience made?
Twist Bioscience has made 3 acquisitions, including Abveris, Genome Compiler Corporation, and iGenomX.
Who are Twist Bioscience's investors?
Twist Bioscience has 21 investors. Key investors include Fidelity Investments, Illumina, SVB, Applied Materials, and FIS.
What is Twist Bioscience's ticker symbol?
The ticker symbol of Twist Bioscience is TWST on NASDAQ.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.